BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22847748)

  • 21. Colloids versus crystalloids for fluid resuscitation in critically ill patients.
    Roberts I; Alderson P; Bunn F; Chinnock P; Ker K; Schierhout G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000567. PubMed ID: 15495001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials.
    Shi XY; Zou Z; He XY; Xu HT; Yuan HB; Liu H
    Eur J Clin Pharmacol; 2011 Aug; 67(8):767-82. PubMed ID: 21365330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colloid solutions for fluid resuscitation.
    Bunn F; Trivedi D; Ashraf S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD001319. PubMed ID: 18253989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of peri-operative administration of hydroxyethyl starch in children undergoing surgery: A systematic review and meta-analysis.
    Thy M; Montmayeur J; Julien-Marsollier F; Michelet D; Brasher C; Dahmani S; Orliaguet G
    Eur J Anaesthesiol; 2018 Jul; 35(7):484-495. PubMed ID: 29419565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colloid solutions for fluid resuscitation.
    Bunn F; Alderson P; Hawkins V
    Cochrane Database Syst Rev; 2003; (1):CD001319. PubMed ID: 12535407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infusion of hydroxyethyl starch-containing fluids.
    Aubron C; Bellomo R
    Minerva Anestesiol; 2013 Sep; 79(9):1088-92. PubMed ID: 24042155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyethyl starch--can the safety problems be ignored?
    Wiedermann CJ
    Wien Klin Wochenschr; 2004 Sep; 116(17-18):583-94. PubMed ID: 15515874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed.
    Hartog CS; Kohl M; Reinhart K
    Anesth Analg; 2011 Mar; 112(3):635-45. PubMed ID: 21304149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxyethyl starch in sepsis.
    Haase NR
    Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials.
    Wiedermann CJ; Dunzendorfer S; Gaioni LU; Zaraca F; Joannidis M
    Crit Care; 2010; 14(5):R191. PubMed ID: 21029460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective cohort study on the incidence of acute kidney injury and death following hydroxyethyl starch (HES 10% 250/0.5/5:1) administration in dogs (2007-2010).
    Hayes G; Benedicenti L; Mathews K
    J Vet Emerg Crit Care (San Antonio); 2016; 26(1):35-40. PubMed ID: 26587795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colloid solutions for fluid resuscitation.
    Bunn F; Alderson P; Hawkins V
    Cochrane Database Syst Rev; 2001; (2):CD001319. PubMed ID: 11405985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyethyl starch: a review of pharmacokinetics, pharmacodynamics, current products, and potential clinical risks, benefits, and use.
    Glover PA; Rudloff E; Kirby R
    J Vet Emerg Crit Care (San Antonio); 2014; 24(6):642-61. PubMed ID: 25158892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular size and origin do not influence the harmful side effects of hydroxyethyl starch on human proximal tubule cells (HK-2) in vitro.
    Bruno RR; Neuhaus W; Roewer N; Wunder C; Schick MA
    Anesth Analg; 2014 Sep; 119(3):570-577. PubMed ID: 25010825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on the comparative safety of colloids: a systematic review of clinical studies.
    Groeneveld AB; Navickis RJ; Wilkes MM
    Ann Surg; 2011 Mar; 253(3):470-83. PubMed ID: 21217516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.
    Gattas DJ; Dan A; Myburgh J; Billot L; Lo S; Finfer S;
    Intensive Care Med; 2013 Apr; 39(4):558-68. PubMed ID: 23407978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversies in the use of hydroxyethyl starch solutions in small animal emergency and critical care.
    Adamik KN; Yozova ID; Regenscheit N
    J Vet Emerg Crit Care (San Antonio); 2015; 25(1):20-47. PubMed ID: 25655725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
    Suttner S; Boldt J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxyethyl starch 130/0.4 for volume replacement therapy in surgical patients: a systematic review and meta-analysis of randomized controlled trials.
    Xu Y; Wang S; He L; Yu H; Yu H
    Perioper Med (Lond); 2021 May; 10(1):16. PubMed ID: 33971968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.